| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5692092 | European Urology | 2017 | 9 Pages |
Abstract
Clinical use of a 12-gene molecular test for disease aggressiveness may help in stratifying patients with non-muscle-invasive bladder cancer to optimal treatment regimens.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Lars Dyrskjøt, Thomas Reinert, Ferran Algaba, Emil Christensen, Daan Nieboer, Gregers G. Hermann, Karin Mogensen, Willemien Beukers, Mirari Marquez, Ulrika Segersten, Søren Høyer, Benedicte P. Ulhøi, Arndt Hartmann, Robert Stöhr, Sven Wach,